Patient characteristics, treatment patterns, and clinical outcomes in patients hospitalized with factor Xa inhibitor-associated major bleeds: A report from the REVERXaL study
Authors
Marc Maegele (ORCID: https://orcid.org/0000-0002-0634-4723)
Patient characteristics, treatment patterns, and clinical outcomes in patients hospitalized with factor Xa inhibitor-associated major bleeds: A report from the REVERXaL study
Marc Maegele, Shoji Yokobori, Vinay Kumar Sehgal, Hungta Chen et al.
Journal
Thrombosis Research
Topics
Atrial Fibrillation Management and Outcomes
article
Patient characteristics, treatment patterns, and clinical outcomes in patients hospitalized with factor Xa inhibitor-associated major bleeds: A report from the REVERXaL study
Marc Maegele, Shoji Yokobori, Vinay Kumar Sehgal, Hungta Chen, Raza Alikhan, Andreas Tiede, Onivefu E. Odelade, Richard Ofori-Asenso, Adam J. Singer, May Nour, Brooks D. Cash, Masahiro Yasaka
article en
Abstract
No abstract available for this paper.
Publication Tag
Thrombosis ResearchVol. 260
Institutions
AstraZeneca (United Kingdom) (GB), University College Hospital (GB), Witten/Herdecke University (DE), University of California, Los Angeles (US), University Hospital of Wales (GB), Baylor University Medical Center (US), Medizinische Hochschule Hannover (DE), Stony Brook School (US), Fukuoka Hospital (JP), AstraZeneca (United States) (US), University College London (GB), Stony Brook University (US), Nippon Medical School (JP)